Mizuho Securities Downgrades Mednax (MD) to Neutral Following Trump Victory

November 9, 2016 7:41 AM EST
Get Alerts MD Hot Sheet
Price: $67.88 +0.16%

Rating Summary:
    11 Buy, 11 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 20 | Down: 36 | New: 11
Trade MD Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Mizuho Securities downgraded Mednax (NYSE: MD) from Buy to Neutral with a price target of $64.00 following Trump win.

Analyst Ann Hynes commented, "We are downgrading our ACA vulnerable stocks (UHS, AMSG and MD) to Buy from Neutral given President-elect Trump's pledge to repeal and replace Obamacare. Even though it is yet seen if he will be able to claw back an entitlement as big as Obamacare, the fear itself will weigh on valuations and, as a result, we no believe these stocks can outperform until we receive clarity on his true intentions."

For an analyst ratings summary and ratings history on Mednax click here. For more ratings news on Mednax click here.

Shares of Mednax closed at $63.15 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Downgrades

Add Your Comment